Browsing by Autor "Jorge Arnold"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
Item type: Item , An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study(Lippincott Williams & Wilkins, 2024) Winston Dunn; Yanming Li; Ashwani K. Singal; Douglas A. Simonetto; Luis Antonio Díaz; Francisco Idalsoaga; Gustavo Ayares; Jorge Arnold; María Ayala-Valverde; Diego PérezHarnessing artificial intelligence within a global consortium, we pioneered a scoring system excelling over traditional models for 30 and 90-day AH mortality predictions. Beneficial for clinical trials, steroid therapy, and transplant indications, it's accessible at: https://aihepatology.shinyapps.io/ALCHAIN/ .Item type: Item , Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study(Elsevier BV, 2021) Juan Pablo Arab; Luis Antonio Díaz; Natalia Baeza; Francisco Idalsoaga; Eduardo Fuentes–López; Jorge Arnold; Carolina Ramírez; Dalia Morales‐Arráez; Meritxell Ventura‐Cots; Edilmar Alvarado‐TápiasItem type: Item , MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis(Elsevier BV, 2023) Luis Antonio Díaz; Eduardo Fuentes–López; Gustavo Ayares; Francisco Idalsoaga; Jorge Arnold; María Ayala-Valverde; Diego Pérez; Jaime Gómez; Rodrigo Escarate; Alejandro VillalónItem type: Item , The establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas(Elsevier BV, 2022) Luis Antonio Díaz; Eduardo Fuentes–López; Gustavo Ayares; Francisco Idalsoaga; Jorge Arnold; Andrea Márquez‐Lomas; Carolina Ramírez; María Paz Medel; Francisca Viñuela; Lucas Lacalle